NCT03778580View on ClinicalTrials.gov

Advanced Glycation Endproducts and Bone Material Strength in T2D Treated With Pyridoxamine

NACompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

February 28, 2022

Study Completion Date

February 28, 2022

Conditions
Diabetes Mellitus, Type 2
Interventions
DIETARY_SUPPLEMENT

Pyridoxamine Dihydrochloride

pyridoxamine dihydrochloride (over- the- counter type of vitamin B6) 200 mg po bid

DRUG

placebo

placebo

Trial Locations (1)

10032

Columbia University Medical Center - Harkness Pavillion, New York

All Listed Sponsors
lead

Columbia University

OTHER

NCT03778580 - Advanced Glycation Endproducts and Bone Material Strength in T2D Treated With Pyridoxamine | Biotech Hunter | Biotech Hunter